About
Johan Lund is a physician and former professor with a PhD from Karolinska Institutet and over 25 years of experience in drug development across academia and industry. He has held senior research leadership roles at AstraZeneca, Pfizer, and Celgene, focusing on inflammation, immunology, and CNS, including serving as Chief Scientific Officer for Inflammation & Immunology at Pfizer. As Venture Partner at Sciety, he supports the evaluation of investment opportunities and helps portfolio companies translate scientific research to market.
Invests in
BiotechHealthtech
Experience
- Mesenkia Therapeutics ABCo-founder and Chairman of the Boardcurrent2025 — presentUppsala, Uppsala County, Sweden
- Mesenkia Therapeutics ABInterim Chief Executive Officer and co-founder2023 — 2025Uppsala, Uppsala County, Sweden
- AQILION ABChief Scientific Officercurrent2021 — present
- AQILION ABChairman Of The Board2018 — 2022Helsingborg, Sweden
- NEOGAP Therapeutics ABChairman of the Board of Directorscurrent2019 — present
- Pelago Bioscience ABMember Board Of Directorscurrent2021 — present
- ScietyVenture Partnercurrent2025 — present
- PharmNovoChairman of the Boardcurrent2025 — present
- MBS PharmaFoundercurrent2018 — presentBjärred, Sweden
- NeuVentis Therapeutics ABCEO and Co-Foundercurrent2018 — presentStockholm, Sweden
- Olink ProteomicsBoard member2017 — 2024Uppsala, Sweden
- LIDDSMember Board Of Directors2022 — 2024
- Genagon TherapeuticsMember Board Of Directors2019 — 2024
- Celgene PharmaVice President2016 — 2017Cambridge, MA
- EIT Health Scandinavian CLCBoard Member2015 — 2016Greater Stockholm Metropolitan Area
- Karolinska InstitutetSenior Specialist & Program Lead EIT Health2015 — 2016Greater Stockholm Metropolitan Area
- J. Lund & Associates, LLCManaging Partner2015 — 2016Brookline, MA
- PfizerSenior Vice President & Chief Scientific Officer, Immunoscience Research Unit2012 — 2015Cambridge, MA, USA
- AstraZenecaVice President2008 — 2012
- AstraZenecaVice President2007 — 2008
Education
- Karolinska InstitutetMD/PhD1978 — 1986
Skills & more
Drug Discovery99Clinical Development41Lifesciences26Drug Development81Neuroscience26Pharmacology35Pharmaceutical Industry54Biomarkers33Molecular Biology99Immunology99Science25In Vivo5
+12 more
Medical AffairsR&DInflammationBiotechnologyBiochemistryTranslational MedicineCROIn VitroINDMedicinal ChemistryClinical TrialsToxicologyFrom Johan's professional profile.
Same school
Shared employers
Also worked at Olink Proteomics4
Also worked at Pfizer118
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
+ 112 more
Also worked at AstraZeneca52
Jung Lee, PhDVenture Partner at Adelphi Ventures Management, LlcAnnie VemuSenior Associate at Longwood FundIliam BarkinoInvestor at IndustrifondenSara JawadInvestor at IndustrifondenDamian Crowtherex-AstraZeneca at PICUS CAPITALEmma HanaeusInvestor at Almi Invest
+ 46 more
Investments
Board seats
MesenkiaNeogap TherapeuticsOlinkPharmNovo
Per the firm's website.
Colleagues at Sciety
Andreas Lindblom
Managing Partner at Sciety
Bengt Julander
Senior Advisor at Sciety
Charlotte Smirnova
Corporate Communications Manager at Sciety
Christina Sterner
Operations & Compliance Manager at Sciety
Daniel Borg
IT Manager at Sciety
Dawid Myslinski
Director – Equity Capital Markets at Sciety
Erik Röjvall
Head of Corporate Finance at Sciety
Fredrik Niléhn
Senior Associate – Corporate Finance at Sciety